San Francisco Sentry Investment Group CA Acquires 687 Shares of UnitedHealth Group Incorporated (UNH)
San Francisco Sentry Investment Group CA grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 9.3% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 8,069 shares of the healthcare conglomerate’s stock after purchasing an additional 687 shares during the period. San Francisco Sentry Investment Group CA’s holdings in UnitedHealth Group were worth $1,496,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also bought and sold shares of UNH. Blue Chip Partners Inc. acquired a new position in UnitedHealth Group during the second quarter worth $110,000. Bruderman Asset Management LLC acquired a new position in UnitedHealth Group during the second quarter worth $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. increased its holdings in UnitedHealth Group by 433.3% during the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after buying an additional 520 shares during the last quarter. BDO Wealth Advisors LLC acquired a new position in UnitedHealth Group during the second quarter worth $121,000. Finally, Kings Point Capital Management increased its holdings in UnitedHealth Group by 27.9% during the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 150 shares during the last quarter. Institutional investors own 86.20% of the company’s stock.
A number of equities analysts recently weighed in on the stock. ValuEngine downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday. Raymond James Financial restated a “buy” rating on shares of UnitedHealth Group in a report on Wednesday, December 6th. Zacks Investment Research downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, September 26th. Jefferies Group restated a “buy” rating and set a $248.00 target price on shares of UnitedHealth Group in a report on Friday, December 1st. Finally, Morgan Stanley boosted their target price on shares of UnitedHealth Group from $210.00 to $215.00 and gave the stock an “overweight” rating in a report on Thursday, August 17th. Three equities research analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the company’s stock. UnitedHealth Group has an average rating of “Buy” and an average target price of $224.56.
In other news, insider Thomas E. Roos sold 975 shares of the business’s stock in a transaction dated Thursday, October 19th. The shares were sold at an average price of $205.47, for a total value of $200,333.25. Following the completion of the sale, the insider now owns 24,630 shares of the company’s stock, valued at $5,060,726.10. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Larry C. Renfro sold 50,574 shares of the business’s stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the completion of the sale, the insider now directly owns 195,625 shares of the company’s stock, valued at approximately $38,755,268.75. The disclosure for this sale can be found here. In the last three months, insiders sold 62,606 shares of company stock valued at $12,677,525. 0.89% of the stock is currently owned by company insiders.
UnitedHealth Group Incorporated (UNH) traded up $3.76 during mid-day trading on Monday, reaching $223.91. 2,233,200 shares of the company’s stock were exchanged, compared to its average volume of 3,110,479. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70. UnitedHealth Group Incorporated has a 1 year low of $156.09 and a 1 year high of $231.77. The company has a market capitalization of $215,500.00, a PE ratio of 23.32, a price-to-earnings-growth ratio of 1.66 and a beta of 0.66.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.57 by $0.09. The company had revenue of $50.32 billion during the quarter, compared to analysts’ expectations of $50.38 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. UnitedHealth Group’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.17 earnings per share. research analysts expect that UnitedHealth Group Incorporated will post 9.99 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st will be given a $0.75 dividend. The ex-dividend date of this dividend is Thursday, November 30th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.34%. UnitedHealth Group’s payout ratio is presently 34.09%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.